Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL. [electronic resource]
- PloS one 2017
- e0173353 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0173353 doi
Adolescent Adult Aged Aged, 80 and over Cohort Studies Disease Progression Female Fingolimod Hydrochloride--therapeutic use Germany Glatiramer Acetate--therapeutic use Humans Interferons--therapeutic use Male Middle Aged Multiple Sclerosis--drug therapy Young Adult